Jeff Geyer
Vice President, Investor Relations
Replay available
Molina Healthcare Inc (NYSE: MOH) Q2 2026 earnings conference call, held 2026-07-23. Replay captured from the company's public earnings webcast.

Vice President, Investor Relations
President and Chief Executive Officer
Chief Financial Officer
Bank of America Securities
Barclays
Wells Fargo
Wolf Research
UBS
JP Morgan
Cantor Fitzgerald
Bernstein
Goldman Sachs
Kuchenheim
Deutsche Bank
Good day and welcome to the Molina Healthcare Second Quarter 2026 Earnings Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad, and to withdraw your question, please press star then two. We do ask that you please limit yourself to one question. Please also note today's event is being recorded. I would now like to turn the conference over to Jeff Geyer, Vice President, Investor Relations. Please go ahead. Good morning and welcome to Molina Healthcare's second quarter 2026 earnings call. Joining me today are Molina's President and CEO, Joseph Zubretsky, and our CFO, Mark Keim. A press release announcing our second quarter 2026 earnings was distributed after the market closed yesterday. and is available on our investor relations website. Shortly after the conclusion of this call, a replay will be available for 30 days. The numbers to access the replay are in the earnings release. For those of you who listened to the rebroadcast of this presentation, we remind you that all of the remarks are made as of today, Thursday, July 23rd, 2026, and have not been updated subsequent to the initial earnings call. On this call, we will refer to certain non-GAAP measures. The reconciliation of these measures with the most directly comparable gap measures can be found in the earnings release. During the call, we will be making certain forward-looking statements, including but not limited to statements regarding our 2026 guidance and the expected performance of each one of our business segments, rates, and the medical cost t...